End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.5 BGN | -1.52% | -1.52% | +1.56% |
Apr. 30 | Formoplast AD Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Jan. 29 | Formoplast AD Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 20.89 | 21.08 | 21.65 | 23.55 | 23.55 | 24.31 |
Enterprise Value (EV) 1 | 20.69 | 20.8 | 21.55 | 23.44 | 23.37 | 24.04 |
P/E ratio | -15.9 x | -264 x | -75 x | -258 x | 689 x | -291 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 15.6 x | 13.5 x | 14.1 x | 19 x | 16.3 x | 17.2 x |
EV / Revenue | 15.4 x | 13.4 x | 14 x | 18.9 x | 16.2 x | 17 x |
EV / EBITDA | -114 x | 125 x | 71.4 x | 361 x | 184 x | 1,336 x |
EV / FCF | 19.3 x | 146 x | 82.7 x | 856 x | -457 x | 189 x |
FCF Yield | 5.18% | 0.68% | 1.21% | 0.12% | -0.22% | 0.53% |
Price to Book | 7.92 x | 8.23 x | 2.4 x | 2.62 x | 2.61 x | 2.58 x |
Nbr of stocks (in thousands) | 3,799 | 3,799 | 3,799 | 3,799 | 3,799 | 3,799 |
Reference price 2 | 5.500 | 5.550 | 5.700 | 6.200 | 6.200 | 6.400 |
Announcement Date | 3/30/18 | 3/29/19 | 7/17/20 | 3/31/21 | 1/27/22 | 3/30/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 1.341 | 1.557 | 1.535 | 1.237 | 1.444 | 1.411 |
EBITDA 1 | -0.182 | 0.167 | 0.302 | 0.065 | 0.127 | 0.018 |
EBIT 1 | -0.454 | -0.102 | -0.164 | -0.11 | 0.014 | -0.101 |
Operating Margin | -33.86% | -6.55% | -10.68% | -8.89% | 0.97% | -7.16% |
Earnings before Tax (EBT) 1 | -1.32 | -0.078 | -0.289 | -0.09 | 0.034 | -0.085 |
Net income 1 | -1.32 | -0.078 | -0.289 | -0.09 | 0.034 | -0.085 |
Net margin | -98.43% | -5.01% | -18.83% | -7.28% | 2.35% | -6.02% |
EPS 2 | -0.3470 | -0.0210 | -0.0760 | -0.0240 | 0.009000 | -0.0220 |
Free Cash Flow 1 | 1.072 | 0.1422 | 0.2605 | 0.0274 | -0.0511 | 0.127 |
FCF margin | 79.91% | 9.14% | 16.97% | 2.21% | -3.54% | 9% |
FCF Conversion (EBITDA) | - | 85.18% | 86.26% | 42.12% | - | 705.56% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/30/18 | 3/29/19 | 7/17/20 | 3/31/21 | 1/27/22 | 3/30/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 0.2 | 0.28 | 0.11 | 0.11 | 0.18 | 0.27 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 1.07 | 0.14 | 0.26 | 0.03 | -0.05 | 0.13 |
ROE (net income / shareholders' equity) | -40% | -3% | -4.99% | -1% | 0.38% | -0.92% |
ROA (Net income/ Total Assets) | -4.44% | -2.03% | -1.64% | -0.73% | 0.09% | -0.66% |
Assets 1 | 29.71 | 3.836 | 17.67 | 12.39 | 36.56 | 12.97 |
Book Value Per Share 2 | 0.6900 | 0.6700 | 2.370 | 2.370 | 2.370 | 2.480 |
Cash Flow per Share 2 | 0.0500 | 0.0700 | 0.0800 | 0.1000 | 0.0600 | 0.0700 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 3/30/18 | 3/29/19 | 7/17/20 | 3/31/21 | 1/27/22 | 3/30/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+1.56% | 13.65M | |
+3.11% | 14.36B | |
+19.79% | 9.81B | |
-11.83% | 6.8B | |
+16.54% | 1.46B | |
+28.00% | 1.43B | |
-13.97% | 1.32B | |
+21.28% | 1.19B | |
-26.79% | 973M | |
+20.60% | 852M |
- Stock Market
- Equities
- FORM Stock
- Financials Formoplast AD